Literature DB >> 12701810

A role for guanidino compounds in the brain.

Midori Hiramatsu1.   

Abstract

Guanidino compounds of guanidinoethanesulfonic acid, guanidinoacetic acid, guanidinosuccinic acid, N-acetylarginine, beta-guanidinopropionic acid, creatinine, gamma-guanidinobutyric acid, arginine, guanidine, methylguanidine, homoarginine and alpha-guanidinoglutaric acid are present in the mammalian brain. These guanidino compounds except for arginine and guanidine induce seizures and convulsions in rat, rabbit and cat by intracisternal injection. Hirudonine, audonine, alpha-keto-delta-guanidinovaleric acid, N,N'-dibenzoylguanidine and phenylethylguanidine are also convulsants. Levels of creatinine, guanidinoethanesulfonic acid, creatinine, guanidinoacetic acid and methylguanidine in animal brain were changed at pre- and during convulsions induced by pentylentetrazol, amygdala kindling, iron-induced epileptogenesis and so on. These convulsions are thought to be due to depressed functions of serotonergic neurons and accumulated free radicals. Arginine is a substrate of nitric oxide production by nitric oxide synthase. alpha-Guanidinoglutaric acid is a generator of superoxide, hydroxyl radicals and nitric oxide, and induced C6 glial cell death. On the other hand, aminoguanidine is a free radical scavenger. Energy formation by creatine metabolism may inhibit apoptosis induced by pathogenesis. Free radical generation/ reaction and energy generation by guanidino compounds must be important key role in the brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701810

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  7 in total

1.  Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats.

Authors:  M Komatsu; M Hiramatsu; L J Willmore
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

2.  [Convulsant action of the diguanide derivatives hirudonine, arcaine and audouine].

Authors:  A Mori; M Hiramatsu; A Numoto; Y Robin
Journal:  C R Seances Soc Biol Fil       Date:  1981

3.  Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex.

Authors:  L J Willmore; G W Sypert; J V Munson; R W Hurd
Journal:  Science       Date:  1978-06-30       Impact factor: 47.728

4.  alpha-Guanidinoglutaric acid in cobalt-induced epileptogenic cerebral cortex of cats.

Authors:  A Mori; M Akagi; Y Katayama; Y Watanabe
Journal:  J Neurochem       Date:  1980-09       Impact factor: 5.372

5.  Measurement during convulsions of guanidino compound levels in cerebrospinal fluid collected with a catheter inserted into the cisterna magna of rabbits.

Authors:  M Hiramatsu; R Edamatsu; N Fujikawa; A Shirasu; M Yamamoto; S Suzuki; A Mori
Journal:  Brain Res       Date:  1988-07-05       Impact factor: 3.252

6.  Convulsive activity of alpha-guanidinoglutaric acid and the possible involvement of 5-hydroxytryptamine in the alpha-guanidinoglutaric acid-induced seizure mechanism.

Authors:  H Shiraga; M Hiramatsu; A Mori
Journal:  J Neurochem       Date:  1986-12       Impact factor: 5.372

7.  Increase of methylguanidine and guanidinoacetic acid in the brain of amygdala-kindled rats.

Authors:  Y Hirayasu; K Morimoto; S Otsuki
Journal:  Epilepsia       Date:  1991 Nov-Dec       Impact factor: 5.864

  7 in total
  22 in total

Review 1.  Advanced physiological roles of guanidinoacetic acid.

Authors:  Sergej M Ostojic
Journal:  Eur J Nutr       Date:  2015-09-28       Impact factor: 5.614

2.  Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.

Authors:  Yunching Chen; Joyeeta Sen; Surendar Reddy Bathula; Qi Yang; Raffaella Fittipaldi; Leaf Huang
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 3.  Biosynthesis, degradation and pharmacological importance of the fatty acid amides.

Authors:  Emma K Farrell; David J Merkler
Journal:  Drug Discov Today       Date:  2008-04-03       Impact factor: 7.851

4.  Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration.

Authors:  Janaína Kolling; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2010-09-10       Impact factor: 3.584

5.  Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer.

Authors:  Yunching Chen; Surendar Reddy Bathula; Jun Li; Leaf Huang
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

6.  Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats.

Authors:  Alexandra I Zugno; Francieli M Stefanello; Emilene B S Scherer; Cristiane Mattos; Carolina D Pederzolli; Vanessa M Andrade; Clovis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho; Angela T S Wyse
Journal:  Neurochem Res       Date:  2008-03-15       Impact factor: 3.996

7.  Early-onset hyperargininaemia: a severe disorder?

Authors:  M Schiff; J-F Benoist; M L Cardoso; M Elmaleh-Bergès; P Forey; J Santiago; H Ogier de Baulny
Journal:  J Inherit Metab Dis       Date:  2009-04-20       Impact factor: 4.982

8.  Guanidinoacetate administration increases acetylcholinesterase activity in striatum of rats and impairs retention of an inhibitory avoidance task.

Authors:  Alexandra I Zugno; Lenir O Pereira; Cristiane Mattos; Emilene B S Scherer; Carlos A Netto; Angela T S Wyse
Journal:  Metab Brain Dis       Date:  2008-04-24       Impact factor: 3.584

9.  Liver transplantation prevents progressive neurological impairment in argininemia.

Authors:  E Santos Silva; M L Cardoso; L Vilarinho; M Medina; C Barbot; E Martins
Journal:  JIMD Rep       Date:  2013-04-05

10.  Effects in vitro of guanidinoacetate on adenine nucleotide hydrolysis and acetylcholinesterase activity in tissues from adult rats.

Authors:  Roselia Maria Spanevello; Angela Terezinha de Souza Wyse; Cinthia Melazzo Mazzanti; Roberta Schmatz; Naiara Stefanello; Jamile Fabbrin Gonçalves; Margarete Bagatini; Vanessa Battisti; Vera Maria Morsch; Maria Rosa Chitolina Schetinger
Journal:  Neurochem Res       Date:  2008-02-07       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.